Ingersoll Rand Surges Into Q3 Print While Peers Fall Back

Ingersoll Rand reports third-quarter results today against a backdrop that has shifted sharply since the previous earnings preview published four days ago: the stock is up 8% over the past week to $80.01, while its closest peers dropped a median of 2.8% over the same period.

That reversal is the defining feature of the current setup. Four days ago, IR was the underperformer in its peer group, down 5.5% on the week to $73.48. Since then, the stock has recaptured those losses and more, trading above where most analyst targets from the April and May round of cuts had implied fair value. FELE fell 4.5% on the week, DCI dropped 4.1%, and CR gave back 2.9%, while ESAB was a notable outlier to the upside at 6.9%. The mean analyst target sits at $94.09, leaving implied upside of roughly 18% from the current price, a narrower gap than it appeared a week ago but still meaningful.

Options positioning has edged slightly more defensive into the print. The put/call ratio is at 0.30, about 1.2 standard deviations above its 20-day average of 0.27. That remains far from extreme: the 52-week high on the PCR is 1.02, and the current reading is near the low end of the past year's range. The lending market continues to give no bearish signal whatsoever. Borrow availability has loosened further to 4,687%, meaning there are roughly 47 shares available to lend for every one currently borrowed. Cost to borrow has fallen 24% over the past week to just 0.35%. Short interest at 3.6% of the free float is modest, and while it rose about 6% over the past week, borrowing conditions remain far too loose to suggest any meaningful short conviction.

Analyst opinion is split between those who see the industrial recovery story intact and those worried about margins. The bull case rests on regional order momentum: high-teens growth in the Americas and low double-digits in APAC, a backlog up 16%, and a book-to-bill ratio above 1.0x pointing to future revenue. The bear case is rooted in what happened at the prior print, when IR cut its 2025 organic sales guidance and the stock fell 11.4% in a session, with adjusted EBITDA margins contracting to 28.6% from 29.7% a year earlier. That prior print landed a one-day gain of 4.1% when the company last reported in July, suggesting the market's reaction function is sensitive to the guidance line rather than the headline beat. The most recent analyst moves of note came in August, when Evercore ISI raised its target to $93 and Baird lifted to $109, both after maintaining their ratings. Morgan Stanley had cut to $80 in June, a level the stock has now eclipsed.

Wikipedia attention is running more than two standard deviations above IR's own 90-day baseline, per Wikimedia Foundation data tracked by ORTEX, though this measures retail interest rather than anything connected to the company's financials.

Today's print is less a test of whether the industrial recovery is real and more a test of whether IR can restore the margin trajectory that the prior quarter called into question, at a price that has already priced in a meaningful part of the recovery.